Sci-Tech News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.

Press releases published on September 14, 2026

Sep. 14, 2026

INmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to Board

Indeterminate GlobeNewswire

Sep. 14, 2026

Brazil Potash reduz capex inicial com contrato de energia de 28 anos para construção e backup

Indeterminate GlobeNewswire

Sep. 14, 2026

Brazil Potash Reduces Upfront Capex with 28-Year Construction & Backup Power Contract

Indeterminate GlobeNewswire

Sep. 14, 2026

Belo Sun Mining Provides Update on Proceedings Related to the Installation License for the Volta Grande Gold Project In Brazil

Indeterminate GlobeNewswire

Sep. 14, 2026

Cullinan Therapeutics to Host Virtual Analyst and Investor Event Today to Feature Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung Cancer

Indeterminate GlobeNewswire

Sep. 14, 2026

Corbus Pharmaceuticals Announces Positive Topline Data from CANYON-1 Study of Daily Oral CRB-913 for the Treatment of Obesity

Indeterminate GlobeNewswire

Sep. 14, 2026

Asimov Announces Cell Line Development Partnership with Sidewinder Therapeutics to Advance 4-Chain Bispecific Antibody for Solid Tumors

Indeterminate GlobeNewswire

Sep. 14, 2026

Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas

Indeterminate GlobeNewswire

Sep. 14, 2026

AirJoule Technologies Acquires BitSink, Adding Profitable AI & HPC Infrastructure Cooling Business

Indeterminate GlobeNewswire

Sep. 14, 2026

Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference

Indeterminate GlobeNewswire

Sep. 14, 2026

Department of Energy Mandates Centralia Unit 2 Remain Available for Operation for Additional 90 Days

Indeterminate GlobeNewswire

Sep. 14, 2026

Four Cross-Generation LTO Tape Migration Myths, Starting With LTO-10

Indeterminate GlobeNewswire

Sep. 14, 2026

Cyllene Therapeutics Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for EG110A in Neurogenic Detrusor Overactivity (NDO)

Indeterminate GlobeNewswire

Sep. 14, 2026

Talisker Provides 2026 Operational Update

Indeterminate GlobeNewswire

Sep. 14, 2026

GeNeuro, Inc., an NRx Company (Nasdaq:NRXP) is awarded European Patent Rights for GNK-301, a novel drug candidate to treat Amyotrophic Lateral Sclerosis (ALS)

Indeterminate GlobeNewswire

Sep. 14, 2026

Photonic Inc. unveils Project VANGUARD, a proposal for a $500M specialized semiconductor manufacturing facility to accelerate commercialization of quantum, AI and defence innovation in Canada

Indeterminate GlobeNewswire

Sep. 14, 2026

Waldencast plc Announces Intention to Voluntarily Delist from Nasdaq and Deregister its Securities under the Exchange Act

Indeterminate GlobeNewswire

Sep. 14, 2026

TRX Gold Announces Major Milestone with Addition to the MVIS® Global Junior Gold Miners Index

Indeterminate GlobeNewswire

Sep. 14, 2026

FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara

Indeterminate GlobeNewswire

Sep. 14, 2026

TRX Gold Delivers Record Q4 2026; Achieves Top End of Production Guidance

Indeterminate GlobeNewswire